The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia
Open accessAbstract
BACKGROUND: Invasive fungal infections (IFIs) are life-threatening complications in neutropenic patients with hematological malignancies. Because early diagnosis of IFI is difficult, new noninvasive, culture-independent diagnostic tools are needed to improve clinical management. Recent studies have reported that detection of 1,3-beta-D-glucan (BG) antigenemia may be useful for diagnosis of IFI. The aim of the present prospective study was to evaluate the usefulness of monitoring BG in patients undergoing chemotherapy for acute leukemia. METHODS: BG antigenemia was measured by a colorimetric assay twice weekly in the absence of fever and daily in the presence of fever. IFIs were classified according to the criteria of the European Organization for Research and Treatment of Cancer/Mycoses Study Group. RESULTS: During 190 consecutive neutropenic episodes (median duration, 22 days; range, 7-113 days) in 95 patients, 30 proven or probable IFIs (13 aspergillosis, 15 candidiasis, and 2 mixed IFIs) were diagnosed. Sensitivity, specificity, positive predictive value, negative predictive value, and efficiency of 2 consecutive BG values > or =7 pg/mL for diagnosis of proven or probable IFI was 0.63 (95% confidence interval, 0.44-0.79), 0.96 (95% confidence interval, 0.89-0.98), 0.79 (95% confidence interval, 0.57-0.92), 0.91 (95% confidence interval, 0.84-0.95), and 0.89, respectively. The time interval between onset of fever as first sign of IFI and BG antigenemia was significantly shorter than the time to diagnosis of IFI by clinical, microbiological, radiological, and/or histopathological criteria (P < .001). BG values >50 pg/mL were observed in only 2 patients, both of whom experienced failure of antifungal therapy. CONCLUSION: Monitoring of BG antigenemia is a useful noninvasive method for early diagnosis of IFI in patients with acute leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Self-citation2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642
Maertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 592
Maertens, J., Verhaegen, J., Lagrou, K., Van Eldere, J., & Boogaerts, M. (2001) · Blood · doi:10.1182/blood.v97.6.1604 · Cited by 513
Marr, K. A., Balajee, S. A., McLaughlin, L., Tabouret, M., Bentsen, C., & Walsh, T. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/422009 · Cited by 483
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
Mennink-Kersten, M. A., Donnelly, J. P., & Verweij, P. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01045-x · Cited by 482
Aspergillus Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
Herbrecht, R., Letscher-Bru, V., Oprea, C., Lioure, B., Waller, J., Campos, F., Villard, O., Liu, K.-L., Natarajan-Amé, S., Lutz, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.004 · Cited by 392
Evaluation of a (1→3)-β- d -Glucan Assay for Diagnosis of Invasive Fungal Infections
Pickering, J. W., Sant, H. W., Bowles, C. A. P., Roberts, W. L., & Woods, G. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5957-5962.2005 · Cited by 379
Empiric antifungal therapy in febrile granulocytopenic patients
(1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90441-5 · Cited by 378
Pazos, C., Pontón, J., & Palacio, A. D. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.299-305.2005 · Cited by 337
Kawazu, M., Kanda, Y., Nannya, Y., Aoki, K., Kurokawa, M., Chiba, S., Motokura, T., Hirai, H., & Ogawa, S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2733-2741.2004 · Cited by 280
Pizzo, P. A., Armstrong, D., Bodey, G., Pauw, B. D., Feld, R., Glauser, M., Gaya, H., Karp, J., Klastersky, J., Todeschini, G., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.3.397 · Cited by 277
Empirical antifungal therapy in febrile granulocytopenic patients
Meunier, F. (1989) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 268
CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS
Calandra, T., Schneider, R., Bille, J., Mosimann, F., & Francioli, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92043-6 · Cited by 239
Self-citationMiyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Segal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R. (2007) · Clinical Infectious Diseases · doi:10.1086/510677 · Cited by 168
Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Vandenbergh, M., Crokaert, F., Engelhard, D., Marchetti, O., Akan, H., Skoutelis, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376637 · Cited by 168
Self-citationReactivity of (1→3)-β- d -Glucan Assay with Commonly Used Intravenous Antimicrobials
Marty, F. M., Lowry, C. M., Lempitski, S. J., Kubiak, D. W., Finkelman, M., & Baden, L. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00658-06 · Cited by 153
Contemporary tools for the diagnosis and management of invasive mycoses
Alexander, B. D., & Pfaller, M. A. (2006) · Clinical Infectious Diseases · doi:10.1086/504491 · Cited by 147
Differences in beta-glucan levels in culture supernatants of a variety of fungi
Odabaşı, Z., Paetznick, V. L., Rodriguez, J. R., Chen, E., McGinnis, M. R., & Ostrosky‐Zeichner, L. (2006) · Medical Mycology · doi:10.1080/13693780500474327 · Cited by 143
Prophylaxis and Aspergillosis — Has the Principle Been Proven?
Pauw, B. E. D., & Donnelly, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejme068266 · Cited by 134
Usami, M., Ohata, A., Horiuchi, T., Nagasawa, K., Wakabayashi, T., & Tanaka, S. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00162.x · Cited by 117
1,3-β-D-Glucan in Patients Receiving Intravenous Amoxicillin–Clavulanic Acid
Mennink‐Kersten, M. A. S. H., Warris, A., & Verweij, P. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmc053340 · Cited by 114
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies
Prella, M., Billé, J., Pugnale, M., Duvoisin, B., Cavassini, M. L., Calandra, T., & Marchetti, O. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.08.015 · Cited by 103
Self-citationFeld, R. D., dePauw, B. E., Berman, S., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3690 · Cited by 99
Weisser, M., Rausch, C. R., Droll, A., Simcock, M., Sendi, P., Steffen, I., Buitrago, C., Sonnet, S., Gratwohl, A. A., Passweg, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/444462 · Cited by 95
Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level
Kanda, H., Kubo, K., Hamasaki, K., Kanda, Y., Nakao, A., Kitamura, T., Fujita, T., Yamamoto, K., & Mimura, T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00802.x · Cited by 94
Sendid, B., Caillot, D., Baccouch-Humbert, B., Klingspor, L., Grandjean, M., Bonnin, A., & Poulain, D. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4551-4558.2003 · Cited by 94
Mori, T., IKEMOTO, H., Matsumura, M., Yoshida, M., Inada, K., Endo, S., Ito, A., Watanabe, S., YAMAGUCHI, H., Mitsuya, M., et al. (1997) · PubMed · Cited by 73
Between Over- and Undertreatment of Invasive Fungal Disease
Pauw, B. E. D. (2005) · Clinical Infectious Diseases · doi:10.1086/496933 · Cited by 55
Ogawa, M., Hori, H., Niiguchi, S., et al. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04030 · Cited by 49
Pauw, B. E. D., Sable, C. A., Walsh, T. J., Lupinacci, R. J., Bourque, M. R., Wise, B. A., Nguyen, B., DiNubile, M. J., & Teppler, H. (2006) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00127.x · Cited by 32
Pauw, B. E. D., & Patterson, T. F. (2005) · Clinical Infectious Diseases · doi:10.1086/430919 · Cited by 27
(1->3) -D-Glucan Assay in the Diagnosis of Invasive Fungal Infections
Upton, A., Leisenring, W. M., & Marr, K. A. (2006) · Clinical Infectious Diseases · doi:10.1086/501130 · Cited by 20
Decisions about Voriconazole versus Liposomal Amphotericin B
(2002) · New England Journal of Medicine · doi:10.1056/nejm200205093461915 · Cited by 14
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationEmerging opportunistic yeast infections
Miceli, M. H., Díaz, J. A., & Lee, S. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70218-8 · Cited by 811
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 704
Metadata
- Authors
- Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J., Calandra, T., & Marchetti, O.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-15
- Volume
- 46
- Issue
- 6
- Pages
- 878-885
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2140672765
- Cited by
- 263
- References
- 41
- FWCI
- 24.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.